NCAM1, also known as CD56, has been used as an IHC diagnostic and prognostic biomarker with high sensitivity and specificity to differentiate PanNETs from other pancreatic cancers [42, 43, 44, 45]. This evidence concerns the gene NCAM1 and pancreatic neoplasm.